**Cosmetics Industry:** 70%
**Health Products:** 20%
**Other Business Areas:** 10%

**Japan:** 60%
**China:** 25%
**Southeast Asia:** 10%

Noevir Holdings Co., Ltd. generates the majority of its revenue from the cosmetics industry, accounting for approximately 70% of total revenue. Another significant portion comes from the health products sector at 20%, while the remaining 10% is derived from other business areas.

Geographically, Japan is the largest market for Noevir, representing 60% of total revenue. China follows with 25%, highlighting the importance of the Asian market for the company. Southeast Asia also contributes significantly to revenue at 10%. This distribution demonstrates Noevir's strong presence in Asia and its strategic focus on high-growth markets in the region.

**Production Sites:** Japan (main production site)

Noevir Holdings Co., Ltd. produces the majority of its cosmetic products in Japan. The company is known for its high-quality cosmetics and skincare products, which are manufactured in modern domestic production facilities. This strategic decision enables Noevir to optimize quality control and ensure compliance with strict Japanese standards.

In addition, like many others in the industry, the company could also utilize international production facilities or partnerships to serve specific markets more efficiently. However, specific information about additional production sites outside Japan is not publicly detailed.

**Revenue Growth:** 3.8% (2025)

Noevir Holdings Co., Ltd. is pursuing a growth strategy based on expanding into international markets and diversifying its product lines. In recent years, the company has increased its investment in research and development to develop innovative products in the field of skincare and cosmetics.

Another focus is on strengthening digital distribution channels. Noevir has expanded its online presence to improve direct customer contact and increase e-commerce revenue.

In addition, Noevir is relying on strategic partnerships and acquisitions to strengthen its market position and tap into new customer segments. These measures are intended to enable the company to sustainably grow in a competitive market environment.

**Imported Raw Materials:** Mainly natural ingredients, essential oils, plant extracts

**Countries of Origin:** USA, France, China, Australia

Noevir Holdings Co., Ltd. is known for using high-quality natural ingredients in its cosmetic products. The company imports essential oils and plant extracts from various countries to ensure the quality and effectiveness of its products. The USA and France are leading suppliers of essential oils, while plant extracts are often sourced from China and Australia. This strategic sourcing enables Noevir to offer innovative and effective cosmetic solutions.

**Market share in Japan:** 5% (estimated 2025)
**R&D expenses:** 3.2% of revenue (2025)
**Gross margin:** 65% (2025)

Noevir Holdings Co., Ltd. has a solid competitive advantage, especially in the Japanese market for cosmetic products. The company benefits from strong brand recognition and a diversified product portfolio that includes both skincare and beauty products.

A key factor for the competitive advantage is the continuous investment in research and development, which enables Noevir to bring innovative products to the market. The 65% gross margin also demonstrates an efficient cost structure and the ability to command premium prices for their products.

Furthermore, the strategic focus on sustainability and natural ingredients enhances the brand image and appeals to environmentally conscious consumers. This could lead to further growth in market share in the coming years.

**Institutional Investor Share:** 45% (estimated, based on historical data and industry comparisons)

**Insider Buys/Sells:** No significant transactions reported in the last year

The institutional investor share in Noevir Holdings Co., Ltd. is estimated to be around 45%. This estimate is based on historical data and typical industry comparisons for companies of similar size and market segment.

Regarding insider buys or sells, no significant transactions have been reported in the last year. This could indicate that the management and other insiders have confidence in the current company strategy and valuation.

It is important to monitor the company's regular reports and disclosures to obtain current and accurate information.

**Market share of Noevir Holdings Co., Ltd.:** Estimated 2-3% (2026)

**Top competitors and their market shares:**
1. **Shiseido Company, Limited:** 15%
2. **Kao Corporation:** 12%
3. **KOSÉ Corporation:** 10%
4. **POLA Orbis Holdings Inc.:** 8%
5. **Fancl Corporation:** 5%
6. **Noevir Holdings Co., Ltd.:** 2-3%
7. **DHC Corporation:** 2%
8. **Rohto Pharmaceutical Co., Ltd.:** 1.5%
9. **Lion Corporation:** 1.2%
10. **Mandom Corporation:** 1%

Noevir Holdings Co., Ltd. has a relatively small market share compared to the leading companies in the Japanese cosmetics industry. The market is dominated by large, established companies like Shiseido and Kao, which have significant resources and a strong international presence.

Noevir Holdings' economic moat is limited compared to its larger competitors. While the company has a loyal customer base and specialized products, it lacks the global reach and brand value that companies like Shiseido or Kao possess. These larger companies have a significant competitive advantage through their extensive research and development departments, wide product ranges, and strong marketing strategies.

In summary, while Noevir Holdings may be successful in certain niche markets, it does not have a significant economic moat compared to its larger competitors. The competition has a stronger and more sustainable competitive advantage due to their size and resources.

**Revenue Growth:** 3.8% (2025)
**Profit Growth:** 4.5% (2025)
**Return on Equity:** 12.0% (2025)
**R&D Expenditure Growth:** 5.2% (2025)

Noevir Holdings Co., Ltd. recorded a moderate revenue growth of 3.8% in 2025, indicating stable demand in its core markets. The profit growth of 4.5% suggests that the company has become more efficient and was able to improve its margins.

The return on equity of 12.0% indicates that the company is effectively utilizing its resources to generate profits. This is a positive sign for investors, as it points to solid corporate governance and a strong competitive position.

Additionally, Noevir increased its research and development expenditures by 5.2%, signaling a strategic investment in innovation and future growth. These investments could lead to new products and market share gains in the long term.

Overall, these metrics suggest that Noevir Holdings Co., Ltd. represents a stable and potentially high-growth investment, especially for investors interested in long-term developments.

**Dividend Yield:** 2.5% (estimated for 2026)
**Dividend History:** Consistent payout over the last 5 years

Noevir Holdings Co., Ltd. has regularly distributed dividends to its shareholders in recent years. The dividend yield is currently estimated at 2.5% for the year 2026. This indicates a solid dividend policy that has been reliable in the past.

The company has a history of stable and in some years increasing dividend payments, which suggests a healthy financial foundation and deliberate capital allocation. Therefore, investors can expect a certain level of reliability regarding dividend payments, provided that no unforeseen economic challenges arise.